Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001437749-18-007986
Filing Date
2018-04-27
Accepted
2018-04-27 16:58:11
Documents
2
Group Members
BOYALIFE (HONG KONG) LTDBOYALIFE GROUP INC.BOYALIFE INVESTMENT INC.XIAOCHUN XUYISHU LI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D bah20180427_sc13d.htm SC 13D 197094
2 EXHIBIT 6 ex_111511.htm EX-99.6 31383
  Complete submission text file 0001437749-18-007986.txt   230300
Mailing Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742
Business Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742 9168585100
CESCA THERAPEUTICS INC. (Subject) CIK: 0000811212 (see all company filings)

EIN.: 943018487 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-40395 | Film No.: 18785219
SIC: 3821 Laboratory Apparatus & Furniture

Mailing Address 2453 S. ARCHER AVE. SUITE B CHICAGO IL 60616
Business Address 2453 S. ARCHER AVE. SUITE B CHICAGO IL 60616 8473616348
Boyalife Asset Holding II, Inc. (Filed by) CIK: 0001738415 (see all company filings)

EIN.: 822872653 | State of Incorp.: CA
Type: SC 13D